Kaneka Corporation (TYO:4118)
Japan · Delayed Price · Currency is JPY | Market Cap | 374.09B +43.0% |
| Revenue (ttm) | 835.98B +3.5% |
| Net Income | 35.66B +58.2% |
| EPS | 581.13 +62.8% |
| Shares Out | 60.14M |
| PE Ratio | 10.70 |
| Forward PE | 12.14 |
| Dividend | 210.00 (3.38%) |
| Ex-Dividend Date | Sep 29, 2026 |
| Volume | 310,700 |
| Open | 6,240.00 |
| Previous Close | 6,246.00 |
| Day's Range | 6,038.00 - 6,277.00 |
| 52-Week Range | 4,113.00 - 6,570.00 |
| Beta | 0.29 |
| Analysts | Hold |
| Price Target | 5,541.67 (-10.91%) |
| Earnings Date | Nov 11, 2026 |
About Kaneka
Kaneka Corporation engages in the manufacture and sale of polyvinyl chloride (PVC), crosslinked PVC, PVC-PVAc polymers, paste PVC, acryl grafted-vinyl chloride copolymer, and chlorinated PVC in Japan, Asia, North America, Europe, and internationally. It offers impact modifiers, processing aids, specialty additives, toughener for thermosetting resins, silyl-terminated polyether, acrylic silicon, terminally reactive liquid acrylic, biodegradable polymer, engineering resin for injection molding, acrylic film, and isobutylene-based thermoplastic el... [Read more]
Financial Performance
In fiscal year 2026, Kaneka's revenue was 811.64 billion, an increase of 0.55% compared to the previous year's 807.20 billion. Earnings were 30.98 billion, an increase of 22.40%.
Financial StatementsAnalyst Summary
According to 6 analysts, the average rating for 4118 stock is "Hold." The 12-month stock price target is ¥5,542, which is a decrease of -10.91% from the latest price.
News
Kaneka Medical America LLC Announces U.S. Launch of WaveSelect 1014 Guidewire
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kaneka Medical America LLC , a subsidiary company of Kaneka Corporation , innovating embolization coil technology for neurovascular therapies, today announc...